Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by CravenRaven101on May 11, 2011 9:34am

181 Views

Post# 18559015

RE: Rounding the Far Post - Hold and Buy Oncolytic

I guess "partnership" is a relative term huh? Partnering with a manufacturer... OR would one consider it a cost reduction initiative? IS Sigma Aldrich manufacturing for a piece of the future action? It almost seems to me like ONC is positioning its self to enter into a licensing agreement... Also checked Sigma Aldrich... WOW that would have been a nice set of coat tails to ride from about 1995... I wonder if they have a DRiP? I like the news this morning... and will be back on board IF anyone wants to sell at $5.30 :oP

It's MY opinion git yer own.

Bullboard Posts

Railtown teams with Québec AI Institute to accelerate initiatives